ATC code B02
Pharmaceutical drug classification
ATC code B02 Antihemorrhagics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup B02 is part of the anatomical group B Blood and blood forming organs.
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB02.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
01B02A Antifibrinolytics
B02AA Amino acids
- B02AA01 Aminocaproic acid
- B02AA02 Tranexamic acid
- B02AA03 Aminomethylbenzoic acid
B02AB Proteinase inhibitors
- B02AB01 Aprotinin
- B02AB02 Alfa1 antitrypsin
- B02AB04 Camostat
- B02AB05 Ulinastatin
02B02B Vitamin K and other hemostatics
B02BA Vitamin K
- B02BA01 Phytomenadione
- B02BA02 Menadione
B02BB Fibrinogen
- B02BB01 Human fibrinogen
B02BC Local hemostatics
- B02BC01 Absorbable gelatin sponge
- B02BC02 Oxidized cellulose
- B02BC03 Tetragalacturonic acid hydroxymethylester
- B02BC05 Adrenalone
- B02BC06 Thrombin
- B02BC07 Collagen
- B02BC08 Calcium alginate
- B02BC09 Epinephrine
- B02BC30 Combinations; e.g. Fibrin glue
B02BD Blood coagulation factors
- B02BD01 Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
- B02BD02 Coagulation factor VIII
- B02BD03 Factor VIII inhibitor bypassing activity
- B02BD04 Coagulation factor IX
- B02BD05 Coagulation factor VII
- B02BD06 von Willebrand factor and coagulation factor VIII in combination
- B02BD07 Coagulation factor XIII
- B02BD08 Coagulation factor VIIa
- B02BD10 von Willebrand factor
- B02BD11 Catridecacog
- B02BD13 Coagulation factor X
- B02BD14 Susoctocog alfa
- B02BD15 Valoctocogene roxaparvovec
- B02BD16 Etranacogene dezaparvovec
- B02BD17 Fidanacogene elaparvovec
- B02BD18 Arvenacogene sanparvovec
- B02BD30 Thrombin
B02BX Other systemic hemostatics
- B02BX01 Etamsylate
- B02BX02 Carbazochrome
- B02BX03 Batroxobin
- B02BX04 Romiplostim
- B02BX05 Eltrombopag
- B02BX06 Emicizumab
- B02BX07 Lusutrombopag
- B02BX08 Avatrombopag
- B02BX09 Fostamatinib
- B02BX10 Concizumab
- B02BX11 Marstacimab
- B02BX12 Fitusiran
Sources and credits
This article is adapted from the Wikipedia article “ATC code B02”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.